Related Experiment Video
Updated: Aug 17, 2025

Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
Published on: March 12, 2022
The role of VCAM-1 in diabetic retinopathy: A systematic review and meta-analysis
Yinglei Xu1, Huabin Hou2, Lei Zhao3
1Department of Medical Genetics, the Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, China; Department of Prenatal Diagnosis Center, the Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, China.
Insights
Vascular cell adhesion molecule-1 (VCAM-1) is elevated in diabetic retinopathy (DR) patients, correlating with disease severity. This suggests VCAM-1 is a potential biomarker for detecting DR.
Area of Science:
- Ophthalmology
- Immunology
- Molecular Biology
Background:
- Vascular cell adhesion molecule-1 (VCAM-1) is implicated in inflammatory processes.
- The specific role of VCAM-1 in diabetic retinopathy (DR) requires further elucidation.
- A meta-analysis on VCAM-1 in DR is currently lacking.
Approach:
- A systematic literature search was conducted to identify studies investigating VCAM-1 in DR.
- A random effects model was employed for meta-analysis.
- The estimated mean difference in VCAM-1 levels between DR and control groups was evaluated.
Key Points:
- Twenty studies were included in the meta-analysis.
- VCAM-1 levels were significantly higher in patients with DR compared to controls (SMD: 0.67, 95% CI: 0.34-1.01, P < 0.0001).
- Subgroup analysis revealed correlations between VCAM-1 levels and sample size, DR type, methodology, and disease severity.
Conclusions:
- Elevated VCAM-1 levels are characteristic of DR.
- VCAM-1 levels are associated with the severity of diabetic retinopathy.
- VCAM-1 shows potential as a diagnostic biomarker for DR.
Objective:
Vascular cell adhesion molecule-1 (VCAM-1) plays a regulatory role in inflammatory diseases. However, the exact role of VCAM-1 in diabetic retinopathy (DR) remains unclear, and there is a lack of meta-analyses.
Methods:
The role of VCAM-1 in DR was screened by database searching. A random effects model was used, and the estimated mean difference was evaluated.
Results:
Twenty articles were included. The level of VCAM-1 increased significantly in the DR group compared with the control group (SMD: 0.67, 95 % CI: 0.34-1.01, P < 0.0001). VCAM-1 levels correlated with sample size and DR type, method and severity based on subgroup analysis.
Conclusion:
A high level of VCAM-1 is present in DR patients and is related to the severity of DR. Therefore, VCAM-1 is a potential detection biomarker for DR.
More Related Videos
10:46Retinal Cryo-sections, Whole-Mounts, and Hypotonic Isolated Vasculature Preparations for Immunohistochemical Visualization of Microvascular Pericytes
Published on: October 7, 2018
04:36Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...